World's Best Scientists 2026 revealed!
Dominique Schols

Dominique Schols

Award Badge
Microbiology
Belgium
2026

D-Index & Metrics

Microbiology

D-Index
100
Citations
36356
World Ranking
408
National Ranking
11

Medicine

D-Index
101
Citations
37945
World Ranking
7969
National Ranking
93

Research.com Recognitions

  • 2026 - Research.com Microbiology in Belgium Leader Award
  • 2025 - Research.com Microbiology in Belgium Leader Award
  • 2023 - Research.com Microbiology in Belgium Leader Award
  • 2022 - Research.com Microbiology in Belgium Leader Award

Overview

Dominique Schols is affiliated with KU Leuven in Belgium and has an extensive research portfolio primarily in the fields of Medicine and Chemistry. Their work spans subfields including Organic Chemistry, Molecular Biology, Infectious Diseases, Oncology, and Immunology.

The scientist's recent publications reflect a focus on viral infections, immune signaling, and drug synthesis. Notable papers include:

  • STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters, 2020, Nature Communications
  • A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate, 2020, Nature
  • Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza, 2021, JCI Insight
  • STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Alkylated benzimidazoles: Design, synthesis, docking, DFT analysis, ADMET property, molecular dynamics and activity against HIV and YFV, 2020, Computational Biology and Chemistry

The scientist frequently publishes in venues such as the European Journal of Medicinal Chemistry, bioRxiv (Cold Spring Harbor Laboratory), Journal of Medicinal Chemistry, Molecules, and Frontiers in Immunology.

Dominique Schols collaborates regularly with several researchers, including:

  • Steven De Jonghe
  • Sandra Claes
  • Tom Van Loy
  • Sam Noppen
  • Leentje Persoons

Their main research topics include:

  • Chemokine receptors and signaling
  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • Synthesis and biological activity
  • Monoclonal and Polyclonal Antibodies Research
  • Synthesis and Biological Evaluation
  • Receptor Mechanisms and Signaling

Best Publications

  • Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

    Rudi Pauwels;Jan Balzarini;Masanori Baba;Robert Snoeck

  • CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity.

    Paola Bezzi;Maria Domercq;Liliana Brambilla;Rossella Galli

  • Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

    Rudi Pauwels;Koen Andries;Jan Desmyter;Dominique Schols

  • AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

    G A Donzella;D Schols;S W Lin;J A Esté

  • Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4

    Dominique Schols;Sofie Struyf;Jo Van Damme;José A. Esté

  • Chloro-1,4-dimethyl-9H-carbazole Derivatives Displaying Anti-HIV Activity

    Carmela Saturnino;Fedora Grande;Stefano Aquaro;Anna Caruso

  • Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.

    Sigrid Hatse;Katrien Princen;Gary Bridger;Erik De Clercq

  • Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine.

    J Balzarini;A Holy;J Jindrich;L Naesens

  • Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection

    Craig W. Hendrix;Ann C. Collier;Michael Marcel Lederman;Dominique Schols

  • Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.

    Paul Proost;Ingrid De Meester;Dominique Schols;Sofie Struyf

  • Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.

    M. Baba;H. Tanaka;E. De Clercq;R. Pauwels

  • AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice.

    Patrick Matthys;Sigrid Hatse;Kurt Vermeire;Anja Wuyts

  • Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents.

    R Pauwels;J Balzarini;D Schols;M Baba

  • The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model.

    Joanna Zmurko;Rafael E. Marques;Dominique Schols;Erik Verbeken

  • The Mannose-Specific Plant Lectins From Cymbidium Hybrid and Epipactis Helleborine and the (N-acetylglucosamine)n-specific Plant Lectin From Urtica Dioica Are Potent and Selective Inhibitors of Human Immunodeficiency Virus and Cytomegalovirus Replication in Vitro

    J Balzarini;J Neyts;D Schols;M Hosoya

  • Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4.

    Dominique Schols;José A Esté;Geoffrey Henson;Erik De Clercq

  • Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.

    E De Clercq;N Yamamoto;R Pauwels;M Baba

  • Macrophage Tropism of Human Immunodeficiency Virus Type 1 Isolates from Brain and Lymphoid Tissues Predicts Neurotropism Independent of Coreceptor Specificity

    Paul R. Gorry;Greg Bristol;Jerome A. Zack;Kimberly Ritola

  • Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro.

    J Balzarini;D Schols;J Neyts;E Van Damme

  • AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity.

    Nicholas W. Lukacs;Aaron Berlin;Dominique Schols;Renato T. Skerlj

  • Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.

    Dominique Schols;Rudi Pauwels;Jan Desmyter;Erik De Clercq

Frequent Co-Authors

Erik De Clercq
Erik De Clercq Rega Institute for Medical Research
Jan Balzarini
Jan Balzarini KU Leuven
Robert Snoeck
Robert Snoeck KU Leuven
Johan Neyts
Johan Neyts Rega Institute for Medical Research
Kristel Van Laethem
Kristel Van Laethem Rega Institute for Medical Research
Gary J. Bridger
Gary J. Bridger Liminal BioSciences (Canada)
Jan Desmyter
Jan Desmyter Rega Institute for Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their knowledge beyond traditional microbiology, several related online degrees offer viable career pathways. Programs like the accelerated medical billing and coding certificate online provide quick entry into the healthcare administration field, combining flexibility with relevant healthcare expertise.

Additionally, a broad range of medical degrees online now enable students to pursue professional careers from remote locations. These degrees cater to various interests, from nursing to healthcare management, facilitating professional growth without traditional campus constraints.

For those interested in public health, accredited online MPH programs easy to get into offer accessible options to earn a Master of Public Health. These programs support career advancement in health policy, epidemiology, and community health initiatives.

Exploring career options like becoming a child life specialist is also valuable. Understanding how much do child life specialists make can assist in evaluating the financial and personal rewards involved in helping children and families navigate medical challenges.

Best Scientists Citing Dominique Schols

Trending Scientists

Recently Published Articles